Global Carglumic Acid Market

Carglumic Acid Comprehensive Study by Form (Orally Disintegrating Tablets, Dispersible Tablets), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-Commerce Channel) Players and Region - Global Market Outlook to 2026

Carglumic Acid Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Carglumic acid is a rare orphan drug that is used to treat hyperammonemia. Hyperammonemia is a rare genetic condition caused by high blood ammonia levels. Increased ammonia entry is a leading cause of neurological disorders such as urea cycle enzyme deficiency, hepatic encephalopathy, Reye's syndrome, many other metabolic disorders, and toxic encephalopathy. The increase in alcohol intake, smoking, and sedentary lifestyles, both of which contribute to the development of cancers, as well as the global prevalence of metabolic disorders such as hepatic encephalopathy, Reye's syndrome, and cirrhosis, are driving the growth of the carglumic acid market. As a result, there is an abundance of ammonia in the blood, which leads to a higher demand for care.This growth is primarily driven by Increasing cases of Neurological Diseases and Increasing Awareness about Health and Increased Spending on Health by Individual.

Major Players, such as Recordati Rare Diseases Inc (United States), Dipharma Francis S.r.l (Italy), Suven Life Sciences Limited (India), Civentichem LLC (United States), Dipharma S A (Switzerland), Apothecon Pharmaceuticals Pvt Ltd (India), Manus Aktteva Biopharma LLP(India), NURAY CHEMICALS(India), NOVITIUM PHARMA LLC (United States) and Biophore India Pharmaceuticals Pvt Ltd ((India) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

January 2021 - CARBAGLU (Carglumic Acid) Tablets 200mg Receives U.S. FDA Approval for a New Indication to Treat Acute Hyperammonemia Associated with Propionic Acidemia and Methylmalonic Acidemia

Market Drivers
  • Increasing cases of Neurological Diseases
  • Increasing Awareness about Health and Increased Spending on Health by Individual

Market Trend

Restraints
  • Side Effects of the drugs

Opportunities
Government Initiatives for Creating Awareness about Cancer and Various Neurological Problems
Challenges
Stringent Regulatory Approvals for Safety and Efficacy

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Carglumic Acid Study Sheds Light on
— The Carglumic Acid Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Carglumic Acid industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Carglumic Acid industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Form
  • Orally Disintegrating Tablets
  • Dispersible Tablets

By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce Channel

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing cases of Neurological Diseases
      • 3.2.2. Increasing Awareness about Health and Increased Spending on Health by Individual
    • 3.3. Market Challenges
      • 3.3.1. Stringent Regulatory Approvals for Safety and Efficacy
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Carglumic Acid, by Form, Distribution Channel and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Carglumic Acid (Value)
      • 5.2.1. Global Carglumic Acid by: Form (Value)
        • 5.2.1.1. Orally Disintegrating Tablets
        • 5.2.1.2. Dispersible Tablets
      • 5.2.2. Global Carglumic Acid by: Distribution Channel (Value)
        • 5.2.2.1. Hospital Pharmacies
        • 5.2.2.2. Retail Pharmacies
        • 5.2.2.3. E-Commerce Channel
      • 5.2.3. Global Carglumic Acid Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Carglumic Acid: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Recordati Rare Diseases Inc (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Dipharma Francis S.r.l (Italy)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Suven Life Sciences Limited (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Civentichem LLC (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Dipharma S A (Switzerland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Apothecon Pharmaceuticals Pvt Ltd (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Manus Aktteva Biopharma LLP(India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. NURAY CHEMICALS(India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. NOVITIUM PHARMA LLC (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Biophore India Pharmaceuticals Pvt Ltd ((India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Carglumic Acid Sale, by Form, Distribution Channel and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Carglumic Acid (Value)
      • 7.2.1. Global Carglumic Acid by: Form (Value)
        • 7.2.1.1. Orally Disintegrating Tablets
        • 7.2.1.2. Dispersible Tablets
      • 7.2.2. Global Carglumic Acid by: Distribution Channel (Value)
        • 7.2.2.1. Hospital Pharmacies
        • 7.2.2.2. Retail Pharmacies
        • 7.2.2.3. E-Commerce Channel
      • 7.2.3. Global Carglumic Acid Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Carglumic Acid: by Form(USD Million)
  • Table 2. Carglumic Acid Orally Disintegrating Tablets , by Region USD Million (2015-2020)
  • Table 3. Carglumic Acid Dispersible Tablets , by Region USD Million (2015-2020)
  • Table 4. Carglumic Acid: by Distribution Channel(USD Million)
  • Table 5. Carglumic Acid Hospital Pharmacies , by Region USD Million (2015-2020)
  • Table 6. Carglumic Acid Retail Pharmacies , by Region USD Million (2015-2020)
  • Table 7. Carglumic Acid E-Commerce Channel , by Region USD Million (2015-2020)
  • Table 8. South America Carglumic Acid, by Country USD Million (2015-2020)
  • Table 9. South America Carglumic Acid, by Form USD Million (2015-2020)
  • Table 10. South America Carglumic Acid, by Distribution Channel USD Million (2015-2020)
  • Table 11. Brazil Carglumic Acid, by Form USD Million (2015-2020)
  • Table 12. Brazil Carglumic Acid, by Distribution Channel USD Million (2015-2020)
  • Table 13. Argentina Carglumic Acid, by Form USD Million (2015-2020)
  • Table 14. Argentina Carglumic Acid, by Distribution Channel USD Million (2015-2020)
  • Table 15. Rest of South America Carglumic Acid, by Form USD Million (2015-2020)
  • Table 16. Rest of South America Carglumic Acid, by Distribution Channel USD Million (2015-2020)
  • Table 17. Asia Pacific Carglumic Acid, by Country USD Million (2015-2020)
  • Table 18. Asia Pacific Carglumic Acid, by Form USD Million (2015-2020)
  • Table 19. Asia Pacific Carglumic Acid, by Distribution Channel USD Million (2015-2020)
  • Table 20. China Carglumic Acid, by Form USD Million (2015-2020)
  • Table 21. China Carglumic Acid, by Distribution Channel USD Million (2015-2020)
  • Table 22. Japan Carglumic Acid, by Form USD Million (2015-2020)
  • Table 23. Japan Carglumic Acid, by Distribution Channel USD Million (2015-2020)
  • Table 24. India Carglumic Acid, by Form USD Million (2015-2020)
  • Table 25. India Carglumic Acid, by Distribution Channel USD Million (2015-2020)
  • Table 26. South Korea Carglumic Acid, by Form USD Million (2015-2020)
  • Table 27. South Korea Carglumic Acid, by Distribution Channel USD Million (2015-2020)
  • Table 28. Taiwan Carglumic Acid, by Form USD Million (2015-2020)
  • Table 29. Taiwan Carglumic Acid, by Distribution Channel USD Million (2015-2020)
  • Table 30. Australia Carglumic Acid, by Form USD Million (2015-2020)
  • Table 31. Australia Carglumic Acid, by Distribution Channel USD Million (2015-2020)
  • Table 32. Rest of Asia-Pacific Carglumic Acid, by Form USD Million (2015-2020)
  • Table 33. Rest of Asia-Pacific Carglumic Acid, by Distribution Channel USD Million (2015-2020)
  • Table 34. Europe Carglumic Acid, by Country USD Million (2015-2020)
  • Table 35. Europe Carglumic Acid, by Form USD Million (2015-2020)
  • Table 36. Europe Carglumic Acid, by Distribution Channel USD Million (2015-2020)
  • Table 37. Germany Carglumic Acid, by Form USD Million (2015-2020)
  • Table 38. Germany Carglumic Acid, by Distribution Channel USD Million (2015-2020)
  • Table 39. France Carglumic Acid, by Form USD Million (2015-2020)
  • Table 40. France Carglumic Acid, by Distribution Channel USD Million (2015-2020)
  • Table 41. Italy Carglumic Acid, by Form USD Million (2015-2020)
  • Table 42. Italy Carglumic Acid, by Distribution Channel USD Million (2015-2020)
  • Table 43. United Kingdom Carglumic Acid, by Form USD Million (2015-2020)
  • Table 44. United Kingdom Carglumic Acid, by Distribution Channel USD Million (2015-2020)
  • Table 45. Netherlands Carglumic Acid, by Form USD Million (2015-2020)
  • Table 46. Netherlands Carglumic Acid, by Distribution Channel USD Million (2015-2020)
  • Table 47. Rest of Europe Carglumic Acid, by Form USD Million (2015-2020)
  • Table 48. Rest of Europe Carglumic Acid, by Distribution Channel USD Million (2015-2020)
  • Table 49. MEA Carglumic Acid, by Country USD Million (2015-2020)
  • Table 50. MEA Carglumic Acid, by Form USD Million (2015-2020)
  • Table 51. MEA Carglumic Acid, by Distribution Channel USD Million (2015-2020)
  • Table 52. Middle East Carglumic Acid, by Form USD Million (2015-2020)
  • Table 53. Middle East Carglumic Acid, by Distribution Channel USD Million (2015-2020)
  • Table 54. Africa Carglumic Acid, by Form USD Million (2015-2020)
  • Table 55. Africa Carglumic Acid, by Distribution Channel USD Million (2015-2020)
  • Table 56. North America Carglumic Acid, by Country USD Million (2015-2020)
  • Table 57. North America Carglumic Acid, by Form USD Million (2015-2020)
  • Table 58. North America Carglumic Acid, by Distribution Channel USD Million (2015-2020)
  • Table 59. United States Carglumic Acid, by Form USD Million (2015-2020)
  • Table 60. United States Carglumic Acid, by Distribution Channel USD Million (2015-2020)
  • Table 61. Canada Carglumic Acid, by Form USD Million (2015-2020)
  • Table 62. Canada Carglumic Acid, by Distribution Channel USD Million (2015-2020)
  • Table 63. Mexico Carglumic Acid, by Form USD Million (2015-2020)
  • Table 64. Mexico Carglumic Acid, by Distribution Channel USD Million (2015-2020)
  • Table 65. Company Basic Information, Sales Area and Its Competitors
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Carglumic Acid: by Form(USD Million)
  • Table 76. Carglumic Acid Orally Disintegrating Tablets , by Region USD Million (2021-2026)
  • Table 77. Carglumic Acid Dispersible Tablets , by Region USD Million (2021-2026)
  • Table 78. Carglumic Acid: by Distribution Channel(USD Million)
  • Table 79. Carglumic Acid Hospital Pharmacies , by Region USD Million (2021-2026)
  • Table 80. Carglumic Acid Retail Pharmacies , by Region USD Million (2021-2026)
  • Table 81. Carglumic Acid E-Commerce Channel , by Region USD Million (2021-2026)
  • Table 82. South America Carglumic Acid, by Country USD Million (2021-2026)
  • Table 83. South America Carglumic Acid, by Form USD Million (2021-2026)
  • Table 84. South America Carglumic Acid, by Distribution Channel USD Million (2021-2026)
  • Table 85. Brazil Carglumic Acid, by Form USD Million (2021-2026)
  • Table 86. Brazil Carglumic Acid, by Distribution Channel USD Million (2021-2026)
  • Table 87. Argentina Carglumic Acid, by Form USD Million (2021-2026)
  • Table 88. Argentina Carglumic Acid, by Distribution Channel USD Million (2021-2026)
  • Table 89. Rest of South America Carglumic Acid, by Form USD Million (2021-2026)
  • Table 90. Rest of South America Carglumic Acid, by Distribution Channel USD Million (2021-2026)
  • Table 91. Asia Pacific Carglumic Acid, by Country USD Million (2021-2026)
  • Table 92. Asia Pacific Carglumic Acid, by Form USD Million (2021-2026)
  • Table 93. Asia Pacific Carglumic Acid, by Distribution Channel USD Million (2021-2026)
  • Table 94. China Carglumic Acid, by Form USD Million (2021-2026)
  • Table 95. China Carglumic Acid, by Distribution Channel USD Million (2021-2026)
  • Table 96. Japan Carglumic Acid, by Form USD Million (2021-2026)
  • Table 97. Japan Carglumic Acid, by Distribution Channel USD Million (2021-2026)
  • Table 98. India Carglumic Acid, by Form USD Million (2021-2026)
  • Table 99. India Carglumic Acid, by Distribution Channel USD Million (2021-2026)
  • Table 100. South Korea Carglumic Acid, by Form USD Million (2021-2026)
  • Table 101. South Korea Carglumic Acid, by Distribution Channel USD Million (2021-2026)
  • Table 102. Taiwan Carglumic Acid, by Form USD Million (2021-2026)
  • Table 103. Taiwan Carglumic Acid, by Distribution Channel USD Million (2021-2026)
  • Table 104. Australia Carglumic Acid, by Form USD Million (2021-2026)
  • Table 105. Australia Carglumic Acid, by Distribution Channel USD Million (2021-2026)
  • Table 106. Rest of Asia-Pacific Carglumic Acid, by Form USD Million (2021-2026)
  • Table 107. Rest of Asia-Pacific Carglumic Acid, by Distribution Channel USD Million (2021-2026)
  • Table 108. Europe Carglumic Acid, by Country USD Million (2021-2026)
  • Table 109. Europe Carglumic Acid, by Form USD Million (2021-2026)
  • Table 110. Europe Carglumic Acid, by Distribution Channel USD Million (2021-2026)
  • Table 111. Germany Carglumic Acid, by Form USD Million (2021-2026)
  • Table 112. Germany Carglumic Acid, by Distribution Channel USD Million (2021-2026)
  • Table 113. France Carglumic Acid, by Form USD Million (2021-2026)
  • Table 114. France Carglumic Acid, by Distribution Channel USD Million (2021-2026)
  • Table 115. Italy Carglumic Acid, by Form USD Million (2021-2026)
  • Table 116. Italy Carglumic Acid, by Distribution Channel USD Million (2021-2026)
  • Table 117. United Kingdom Carglumic Acid, by Form USD Million (2021-2026)
  • Table 118. United Kingdom Carglumic Acid, by Distribution Channel USD Million (2021-2026)
  • Table 119. Netherlands Carglumic Acid, by Form USD Million (2021-2026)
  • Table 120. Netherlands Carglumic Acid, by Distribution Channel USD Million (2021-2026)
  • Table 121. Rest of Europe Carglumic Acid, by Form USD Million (2021-2026)
  • Table 122. Rest of Europe Carglumic Acid, by Distribution Channel USD Million (2021-2026)
  • Table 123. MEA Carglumic Acid, by Country USD Million (2021-2026)
  • Table 124. MEA Carglumic Acid, by Form USD Million (2021-2026)
  • Table 125. MEA Carglumic Acid, by Distribution Channel USD Million (2021-2026)
  • Table 126. Middle East Carglumic Acid, by Form USD Million (2021-2026)
  • Table 127. Middle East Carglumic Acid, by Distribution Channel USD Million (2021-2026)
  • Table 128. Africa Carglumic Acid, by Form USD Million (2021-2026)
  • Table 129. Africa Carglumic Acid, by Distribution Channel USD Million (2021-2026)
  • Table 130. North America Carglumic Acid, by Country USD Million (2021-2026)
  • Table 131. North America Carglumic Acid, by Form USD Million (2021-2026)
  • Table 132. North America Carglumic Acid, by Distribution Channel USD Million (2021-2026)
  • Table 133. United States Carglumic Acid, by Form USD Million (2021-2026)
  • Table 134. United States Carglumic Acid, by Distribution Channel USD Million (2021-2026)
  • Table 135. Canada Carglumic Acid, by Form USD Million (2021-2026)
  • Table 136. Canada Carglumic Acid, by Distribution Channel USD Million (2021-2026)
  • Table 137. Mexico Carglumic Acid, by Form USD Million (2021-2026)
  • Table 138. Mexico Carglumic Acid, by Distribution Channel USD Million (2021-2026)
  • Table 139. Research Programs/Design for This Report
  • Table 140. Key Data Information from Secondary Sources
  • Table 141. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Carglumic Acid: by Form USD Million (2015-2020)
  • Figure 5. Global Carglumic Acid: by Distribution Channel USD Million (2015-2020)
  • Figure 6. South America Carglumic Acid Share (%), by Country
  • Figure 7. Asia Pacific Carglumic Acid Share (%), by Country
  • Figure 8. Europe Carglumic Acid Share (%), by Country
  • Figure 9. MEA Carglumic Acid Share (%), by Country
  • Figure 10. North America Carglumic Acid Share (%), by Country
  • Figure 11. Global Carglumic Acid share by Players 2020 (%)
  • Figure 12. Global Carglumic Acid share by Players (Top 3) 2020(%)
  • Figure 13. Global Carglumic Acid share by Players (Top 5) 2020(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Recordati Rare Diseases Inc (United States) Revenue, Net Income and Gross profit
  • Figure 16. Recordati Rare Diseases Inc (United States) Revenue: by Geography 2020
  • Figure 17. Dipharma Francis S.r.l (Italy) Revenue, Net Income and Gross profit
  • Figure 18. Dipharma Francis S.r.l (Italy) Revenue: by Geography 2020
  • Figure 19. Suven Life Sciences Limited (India) Revenue, Net Income and Gross profit
  • Figure 20. Suven Life Sciences Limited (India) Revenue: by Geography 2020
  • Figure 21. Civentichem LLC (United States) Revenue, Net Income and Gross profit
  • Figure 22. Civentichem LLC (United States) Revenue: by Geography 2020
  • Figure 23. Dipharma S A (Switzerland) Revenue, Net Income and Gross profit
  • Figure 24. Dipharma S A (Switzerland) Revenue: by Geography 2020
  • Figure 25. Apothecon Pharmaceuticals Pvt Ltd (India) Revenue, Net Income and Gross profit
  • Figure 26. Apothecon Pharmaceuticals Pvt Ltd (India) Revenue: by Geography 2020
  • Figure 27. Manus Aktteva Biopharma LLP(India) Revenue, Net Income and Gross profit
  • Figure 28. Manus Aktteva Biopharma LLP(India) Revenue: by Geography 2020
  • Figure 29. NURAY CHEMICALS(India) Revenue, Net Income and Gross profit
  • Figure 30. NURAY CHEMICALS(India) Revenue: by Geography 2020
  • Figure 31. NOVITIUM PHARMA LLC (United States) Revenue, Net Income and Gross profit
  • Figure 32. NOVITIUM PHARMA LLC (United States) Revenue: by Geography 2020
  • Figure 33. Biophore India Pharmaceuticals Pvt Ltd ((India) Revenue, Net Income and Gross profit
  • Figure 34. Biophore India Pharmaceuticals Pvt Ltd ((India) Revenue: by Geography 2020
  • Figure 35. Global Carglumic Acid: by Form USD Million (2021-2026)
  • Figure 36. Global Carglumic Acid: by Distribution Channel USD Million (2021-2026)
  • Figure 37. South America Carglumic Acid Share (%), by Country
  • Figure 38. Asia Pacific Carglumic Acid Share (%), by Country
  • Figure 39. Europe Carglumic Acid Share (%), by Country
  • Figure 40. MEA Carglumic Acid Share (%), by Country
  • Figure 41. North America Carglumic Acid Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Recordati Rare Diseases Inc (United States)
  • Dipharma Francis S.r.l (Italy)
  • Suven Life Sciences Limited (India)
  • Civentichem LLC (United States)
  • Dipharma S A (Switzerland)
  • Apothecon Pharmaceuticals Pvt Ltd (India)
  • Manus Aktteva Biopharma LLP(India)
  • NURAY CHEMICALS(India)
  • NOVITIUM PHARMA LLC (United States)
  • Biophore India Pharmaceuticals Pvt Ltd ((India)
Select User Access Type

Key Highlights of Report


Apr 2021 225 Pages 54 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Carglumic Acid Market Quantitative research analysis
Global Carglumic Acid Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Carglumic Acid Market Report?

Have a Query? Click Here

Other Related Reports

Risedronate Sodiums Comprehensive Study by Type (Generic, Branded), Application (Hospital Use, Clinic Use), Risedronate Strength (5 mg, 30 mg, 35 mg), Dosage Form (Capsule, Tablet, Injection) Player...
$ 3500
Palbociclib Comprehensive Study by Type (Tablets, Capsules), Distribution Channel (Online Pharmacies, Retail Pharmacies), End-Users (Hospitals, Diagnostic Centres, Research Institutes), Strength (5mg...
$ 3500
Antibiotics Active Pharmaceutical Ingredient Comprehensive Study by Type (Penicillin Antibiotics, Cephalosporins, Carbapenem Antibiotics), Application (Pharmaceutical Companies, Contract Manufacturin...
$ 3450
Levothyroxine Sodium Tablet Comprehensive Study by Application (Hospital, Specialty Clinic), Treatment (Goiters, Thyroid cancer), Packaging (Bottle, Blister), Dosage (25mcg – 50mcg, 50mcg – 75mcg, 75...
$ 3350
Trulicity Comprehensive Study by Distribution Channel (Specialty Pharma Retail Stores, Hospitals Pharma), Dosage (Less than 1mg, 1mg - 2mg, 2mg - 3mg, 3mg - 4mg, More than 4mg) Players and Region - G...
$ 3500
Rilonacept Drugs Comprehensive Study by Application (Pediatric, Adult, Geriatric), Treatment (Familial Cold Urticaria Syndrome (FCUS), Muckle-Wells Syndrome (MWS), Neonatal Onset Multisystem Inflamma...
$ 3450